State Of Wyoming Acadia Pharmaceuticals Inc Transaction History

State Of Wyoming

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $136,192 - $208,220	6,554 Added 443.14%	8,033 $251,000
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $65,562 - $105,296	-3,146 Reduced 68.02%	1,479 $30,000
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $82,325 - $118,631	4,625 New	4,625 $110,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $82,132 - $107,755	5,784 New	5,784 $92,000
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $90,640 - $189,641	-6,967 Reduced 55.66%	5,550 $78,000
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $19,432 - $25,520	928 Added 8.01%	12,517 $304,000
Q4 2021 Feb 11, 2022	BUY	$16.79 - $27.09 $34,772 - $56,103	2,071 Added 21.76%	11,589 $271,000
Q3 2021 Feb 11, 2022	SELL	$15.78 - $24.77 $4,339 - $6,811	-275 Reduced 2.81%	9,518 $158,000
Q2 2021 Feb 11, 2022	BUY	$19.4 - $27.42 $157,896 - $223,171	8,139 Added 492.08%	9,793 $239,000
Q1 2021 Feb 08, 2022	BUY	$25.02 - $54.99 $41,383 - $90,953	1,654 New	1,654 $43,000

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.